Wednesday, June 10, 2026

pharma Β· Infertility Β· Ovarian Cancer Β· NWBO

NORTHWEST BIOTHERAPEUTICS

NORTHWEST BIOTHERAPEUTICS clinical programs β€” 11 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

4800 Montgomery Lane, Suite 800, Bethesda, MD 28014, US HQ
1998 Founded
20 Employees
Public company Type
NWBO Β· NYSE Ticker
Company details
Status
Public
HQ
4800 Montgomery Lane, Suite 800, Bethesda, MD 28014, US
Founded
1998
Employees
20
Programs
33
Drugs
40
Patents
595
Intelligence Β· Clinical Programs

NORTHWEST BIOTHERAPEUTICS projects

11 ClinicalTrials.gov programs sponsored by NORTHWEST BIOTHERAPEUTICS.

NORTHWEST BIOTHERAPEUTICS has 11 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Carvedilol

    NORTHWEST BIOTHERAPEUTICS INC

    Post-Traumatic Stress Disorder

    phase 2 small molecule active

    1 trial
  2. DCVax-Direct

    NORTHWEST BIOTHERAPEUTICS INC

    Locally Advanced Tumor

    phase 2 mab active

    1 trial
  3. DCVax-L and T Cells

    NORTHWEST BIOTHERAPEUTICS INC

    Ovarian Cancer

    phase 2 mab terminated

    1 trial
  4. Leuprolide or goserelin

    NORTHWEST BIOTHERAPEUTICS INC

    Cancer

    phase 2 small molecule completed

    1 trial
  5. Lithium Carbonate

    NORTHWEST BIOTHERAPEUTICS INC

    Major Depressive Disorder

    phase 2 small molecule completed

    1 trial
  6. PRODIGE 107-ENGIC01-COLOSOTO

    NORTHWEST BIOTHERAPEUTICS INC

    Colorectal Carcinoma

    phase 2 small molecule active

    1 trial
  7. Pear

    NORTHWEST BIOTHERAPEUTICS INC

    Metabolic Syndrome

    phase 2 other completed

    1 trial
  8. Premier Lifestyle Intervention with DASH Diet

    NORTHWEST BIOTHERAPEUTICS INC

    Weight Loss

    phase 2 other completed

    1 trial
  9. Vitamin E

    NORTHWEST BIOTHERAPEUTICS INC

    Nonalcoholic Fatty Liver Disease

    phase 2 small molecule completed

    1 trial
  10. Xanthohumol

    NORTHWEST BIOTHERAPEUTICS INC

    Crohn Disease

    phase 2 small molecule active

    1 trial
  11. autologous dendritic cells pulsed with tumor lysate antigen Vaccine

    NORTHWEST BIOTHERAPEUTICS INC

    Giant Cell Glioblastoma

    phase 2 mab terminated

    1 trial

Frequently asked questions

How many clinical projects does NORTHWEST BIOTHERAPEUTICS have?

11 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.